Published Date:2023-02-24 Original Link:https://www.onenessbio.com/en/news_detail203_4.htm No 1 Date of announcement 2023/02/24 Time of announcement 17:42:58 Subject The Board of Directors resolved to distribute dividends. To which item it meets paragraph 14 Date of events 2023/02/24 Statement Date of the board of directors resolution:2023/02/24 Year or quarter which dividends belong to :2022 Period which dividends belong to:2022/01/01~2022/12/31...Read More
Published Date:2023-02-24 Original Link:https://www.onenessbio.com/en/news_detail202_4.htm No 1 Date of announcement 2023/02/24 Time of announcement 17:30:05 Subject The Company’s 2022 consolidated financial statements have been approved by the Board of Directors To which item it meets paragraph 31 Date of events 2023/02/24 Statement Date of the board of directors submitted or approved:2023/02/24 Date of the audit committee...Read More
Published Date:2023-02-18 Original Link:https://www.onenessbio.com/en/news_detail201_4.htm No 1 Date of announcement 2023/02/18 Time of announcement 22:04:22 Subject Oneness was notified today that Bonvadis, the wound care topical cream has obtained import license in India. To which item it meets paragraph 10 Date of events 2023/02/18 Statement Product:Bonvadis topical cream for wound care Mass production date:NA Effect on...Read More
Published Date:2023-01-31 Original Link:https://www.onenessbio.com/en/news_detail199_5.htm No 2 Date of announcement 2023/01/31 Time of announcement 18:19:35 Subject Oneness Board of Directors resolved to convene the Annual Shareholders’ Meeting of 2023. To which item it meets paragraph 17 Date of events 2023/01/31 Statement Date of the board of directors resolution:2023/01/31 General shareholders’ meeting date:2023/04/18 General shareholders’ meeting location:Building...Read More
Published Date:2023-01-31 Original Link:https://www.onenessbio.com/en/news_detail198_5.htm No 1 Date of announcement 2023/01/31 Time of announcement 18:16:51 Subject Oneness received new drug approval by Singapore HSA on its DFU new drug, FESPIXON. To which item it meets paragraph 10 Date of events 2023/01/31 Statement Product:FESPIXON, a new drug for the treatment of diabetic foot ulcer Mass production date:NA...Read More
Published Date:2023-01-17 Original Link:https://www.onenessbio.com/en/news_detail196_5.htm No 2 Date of announcement 2023/01/17 Time of announcement 18:28:34 Subject An U.S. patent titled “METHOD FOR PREPARING PLECTRANTHUS AMBOINICUS FRACTION HAVING ANTI-ARTHRITIS ACTIVITY” has been granted. To which item it meets paragraph 53 Date of events 2023/01/17 Statement Date of occurrence of the event:2023/01/17 Company name:ONENESS BIOTECH CO., LTD. Relationship...Read More
Published Date:2023-01-13 Original Link:https://www.onenessbio.com/en/news_detail195_5.htm No 1 Date of announcement 2023/01/13 Time of announcement 15:16:40 Subject The CEA of Fespixon based on its significant clinical efficacy showed its cost-effectiveness for treating DFUs. The manuscript was published by JAMA Network Open To which item it meets paragraph 53 Date of events 2023/01/13 Statement Date of occurrence of...Read More
Published Date:2023-01-11 Original Link:https://www.onenessbio.com/en/news_detail194_5.htm No 1 Date of announcement 2023/01/11 Time of announcement 01:54:34 Subject The exploratory trial result of Fespixon in improving postoperative scar cosmesis has been published by a renowned SCI journal, Aesthetic Surgery Journal. To which item it meets paragraph 53 Date of events 2023/01/10 Statement Date of occurrence of the event:2023/01/10...Read More
